SW US: Anfield wants $50M for Utah mill
Anfield Energy (TSXV, Nasdaq: AEC) plans to raise $50M to refurbish Utah's Shootaring Canyon mill, aiming for a 2028 reopening. The mill will process uranium and vanadium, reducing U.S. reliance on imports. Capital expenditures are estimated at $80.1M, with flexibility in financing options. The company expects a mill licence by late 2024 or early 2027, unlocking financing and construction. An updated PEA forecasts significant after-tax NPV and IRR, with production from Velvet-Wood and Slick Rock
How this was made
The 30-second read
Why it matters
The financing announcement provides a concrete catalyst that could drive the stock higher if milestones are met.
Market read
New capital raise and mill reopening plan create a material near‑term catalyst for AEC and the domestic uranium sector.
What to watch
Regulatory approval risk and the need for additional capital to add the vanadium circuit could strain cash flow.
Background
Anfield Energy (TSXV, Nasdaq: AEC) aims to restart the only operating uranium mill in the U.S., targeting both uranium and vanadium markets.
Ticker impact
Anfield Energy disclosed a plan to raise at least $50 million to refurbish and restart the Shootaring Canyon uranium mill, a new financing initiative not previously reported.
Upward pressure if financing is secured and licensing approved.
The disclosed capital raise and timeline provide a clear catalyst; successful financing would materially improve cash flow and project economics.
Market effects
Uranium and vanadium sector could see increased supply and reduced import reliance for the U.S.
Utah mining community may benefit from job creation and economic activity.
Potential to shift a portion of U.S. uranium demand from imports to domestic production.
Counterpoint
Financing may be delayed or insufficient, and licensing hurdles could push the timeline further out, limiting near‑term upside.
Key entities
- ExecutiveCorey Dias
CEO of Anfield Energy, providing the financing outlook.
- AnalystRed Cloud Securities
Analyst calling the licence grant a needle‑mover for the stock.
